WO2002072824A3 - Regulation du canal potentiel humain du recepteur transitoire humain - Google Patents
Regulation du canal potentiel humain du recepteur transitoire humain Download PDFInfo
- Publication number
- WO2002072824A3 WO2002072824A3 PCT/EP2002/001727 EP0201727W WO02072824A3 WO 2002072824 A3 WO2002072824 A3 WO 2002072824A3 EP 0201727 W EP0201727 W EP 0201727W WO 02072824 A3 WO02072824 A3 WO 02072824A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transient receptor
- receptor potential
- potential channel
- human transient
- channel protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/467,163 US20040115675A1 (en) | 2002-02-19 | 2002-02-19 | Regulation of human transient receptor potential channel |
AU2002233343A AU2002233343A1 (en) | 2001-02-20 | 2002-02-19 | Human transient receptor potential channel protein. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26941101P | 2001-02-20 | 2001-02-20 | |
US60/269,411 | 2001-02-20 | ||
US35002102P | 2002-01-23 | 2002-01-23 | |
US60/350,021 | 2002-01-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002072824A2 WO2002072824A2 (fr) | 2002-09-19 |
WO2002072824A3 true WO2002072824A3 (fr) | 2002-12-19 |
Family
ID=26953680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/001727 WO2002072824A2 (fr) | 2001-02-20 | 2002-02-19 | Regulation du canal potentiel humain du recepteur transitoire humain |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002233343A1 (fr) |
WO (1) | WO2002072824A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223557B2 (en) | 2001-05-22 | 2007-05-29 | Bristol-Myers Squibb Company | Polynucleotide encoding a TRP channel family member, TRP-PLIK2 |
JPWO2003033727A1 (ja) | 2001-10-12 | 2005-02-03 | 山之内製薬株式会社 | 細胞死抑制剤スクリーニング法 |
US20050182011A1 (en) * | 2003-11-13 | 2005-08-18 | Eric Olson | Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure |
BRPI0519807A2 (pt) | 2005-01-12 | 2009-03-17 | Sanofi Aventis | uso de um canal trpc para o tratamento de uma doença cardiovascular |
US8221753B2 (en) | 2009-09-30 | 2012-07-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
UA115789C2 (uk) | 2012-09-05 | 2017-12-26 | Трейкон Фармасутікалз, Інк. | Композиція антитіла до cd105 та її застосування |
US10214590B2 (en) | 2013-09-20 | 2019-02-26 | Tufts Medical Center, Inc. | Inhibitors of endoglin activity for the treatment of fibrosis |
CA2966905A1 (fr) | 2014-11-12 | 2016-05-19 | Tracon Pharmaceuticals, Inc. | Anticorps anti-endogline et leurs utilisations |
US9926375B2 (en) | 2014-11-12 | 2018-03-27 | Tracon Pharmaceuticals, Inc. | Anti-endoglin antibodies and uses thereof |
-
2002
- 2002-02-19 WO PCT/EP2002/001727 patent/WO2002072824A2/fr not_active Application Discontinuation
- 2002-02-19 AU AU2002233343A patent/AU2002233343A1/en not_active Abandoned
Non-Patent Citations (7)
Title |
---|
DATABASE EMBL_HUM 10 April 2001 (2001-04-10), RYAZANOV A G: "Homo sapiens channel kinase 3 (CHAK2) mRNA, complete cds", XP002213175 * |
DATABASE EMBL_HUM 29 September 2000 (2000-09-29), SUGANO S ET AL: "Homo sapiens cDNA: FLJ22628 fis, clone HSI06177", XP002213173 * |
DATABASE MEDLINE [online] March 2001 (2001-03-01), RIAZANOVA L V ET AL: "[Novel type of signaling molecules: protein kinases covalently linked to ion channels]", XP002213174, Database accession no. NLM11357414 * |
HARTENECK C ET AL: "FROM WORM TO MAN: THREE SUBFAMILIES OF TRP CHANNELS", TRENDS IN NEUROSCIENCE, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 4, April 2000 (2000-04-01), pages 159 - 166, XP001018915, ISSN: 0166-2236 * |
MOLEKULIARNAIA BIOLOGIIA. RUSSIA 2001 MAR-APR, vol. 35, no. 2, March 2001 (2001-03-01), pages 321 - 332, ISSN: 0026-8984 * |
NAGAMINE K ET AL: "MOLECULAR CLONING OF A NOVEL PUTATIVE CA2+ CHANNEL PROTEIN (TRPC7) HIGHLY EXPRESSED IN BRAIN", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 54, no. 1, 1998, pages 124 - 131, XP000938744, ISSN: 0888-7543 * |
SCHLINGMANN KARL P ET AL: "Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.", NATURE GENETICS. UNITED STATES JUN 2002, vol. 31, no. 2, June 2002 (2002-06-01), pages 166 - 170, XP001104558, ISSN: 1061-4036 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002233343A1 (en) | 2002-09-24 |
WO2002072824A2 (fr) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002072824A3 (fr) | Regulation du canal potentiel humain du recepteur transitoire humain | |
WO2002020731A3 (fr) | Regulation de l'enzyme humaine du type proteine disulfide isomerase | |
WO2002070675A3 (fr) | Regulation de l'histone acetyltransferase humaine | |
WO2002062974A3 (fr) | Regulation de la proteine humaine elongase hselo1 | |
WO2002088362A3 (fr) | Regulation d'une proteine semblable a la prostaglandine-f synthase 1 humaine | |
WO2002072825A3 (fr) | Regulation de la proteine humaine de type mrp5 | |
WO2002032938A3 (fr) | Regulation de la proteine humaine de type pgc-1 | |
WO2002062975A3 (fr) | Regulation de la proteine humaine du type elongase hselo1 | |
WO2002033080A3 (fr) | Regulation du recepteur humain membranaire liant la netrine unc5h-1 | |
WO2002081705A3 (fr) | Regulation de la proteine humaine de type acetyltransferase gnat | |
WO2002057461A3 (fr) | Regulation de la metalloprotease a zinc de type adam-ts humaine | |
WO2002088363A3 (fr) | Regulation de nouvelles prolyl 4-hydroxylases humaines | |
WO2003052088A3 (fr) | Regulation de la sialyltransferase humaine | |
WO2002046403A3 (fr) | Regulation de la proteine humaine du type 'patched' | |
WO2003033708A3 (fr) | Regulation de la proteine kinase humaine a serine/threonine | |
WO2002036613A3 (fr) | Regulation de la proteine humaine de type 'patched' | |
WO2003025174A3 (fr) | Regulation de la proteine humaine de type mrp1 | |
WO2002018566A3 (fr) | Regulation d'enzyme de type l-asparaginase humaine | |
WO2002036781A3 (fr) | Regulation de la glutathione-s-transferase humaine | |
WO2003018786A3 (fr) | Serine/threonine kinase humaine | |
WO2002026999A3 (fr) | Regulation de la proteine humaine de type adam-ts | |
WO2003033709A3 (fr) | Regulation de la proteine kinase serine/threonine humaine | |
WO2002055710A3 (fr) | Regulation de l'acide phosphatase pourpre humain | |
WO2003025162A3 (fr) | Regulation du precurseur de la sous-unite alpha de prolyl 4-hydroxylase humaine | |
WO2002051989A3 (fr) | Regulation de la 4-nitrophenylphosphatase humaine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10467163 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |